MAPT and Alzheimer disease: AD is manifested with progressive cognitive decline and is characterized by multiple pathological hallmarks, including extracellular amyloid beta (Aβ) plaques, intracellular microtubule-associated tau neurofibrillary tangles (NFTs), neuroinflammation, synapse/neuronal loss, and brain atrophy [2, 4, 6].